You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post-transplant lymphoproliferative disease (PTLD)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm

Not yet recruiting
  • EBV Lymphoma
  • Post-transplant Lymphoproliferative Disease (PTLD)
  • Donor-derived ex-vivo expanded EBV Tscm CTL
  • Basel, Switzerland
  • +7 more
Jan 25, 2023

Posttransplant Lymphoproliferative Disorder Trial in Germany (Rituximab sc, Rituximab sc consolidation, Rituximab sc combined

Completed
  • Posttransplant Lymphoproliferative Disorder
  • Rituximab sc
  • +3 more
  • Aachen, Germany
  • +17 more
Aug 22, 2022

Post-transplant Lymphoproliferative Disorder Trial in Saint Louis (Polatuzumab vedotin, Rituximab, CHP)

Not yet recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Polatuzumab vedotin
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 9, 2023

Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)

Active, not recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 16, 2023

Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

Available
  • Epstein-Barr Virus (EBV) Infections
  • +11 more
  • tabelecleucel
  • (no location specified)
Feb 15, 2022

Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder Trial

Not yet recruiting
  • Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
  • Polymorphic Post-Transplant Lymphoproliferative Disorder
  • Biopsy
  • +5 more
  • New Brunswick, New Jersey
  • +2 more
Mar 23, 2023

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

Recruiting
  • Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
  • +4 more
  • tabelecleucel
  • Duarte, California
  • +70 more
Jun 23, 2022

Epstein-Barr Virus Infection moniToring in renAl Transplant

Recruiting
  • EBV Infection
  • +3 more
  • EBV DNA in whole blood and plasma
  • Aarhus, Central Region Denmark, Denmark
  • +2 more
Dec 12, 2022

Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+

Recruiting
  • Epstein-Barr Virus (EBV)-Associated Diseases
  • +13 more
  • Tabelecleucel
  • Los Angeles, California
  • +39 more
Nov 9, 2022

Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic Malignancy Trial in London (Autologous EBV-CTL

Active, not recruiting
  • Post-transplant Lymphoproliferative Disease
  • Transplant-Related Hematologic Malignancy
  • Autologous EBV-CTL transduced with vector SFG-CNA12
  • +2 more
  • London, United Kingdom
  • +1 more
Jan 19, 2022

Early Detection of Epstein-Barr Virus Related Disease.

Active, not recruiting
  • Post-transplant Lymphoproliferative Disorder
  • +8 more
    • Aarhus, Central Region Of Denmark, Denmark
      Aarhus University Hospital
    Dec 12, 2022

    Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

    Completed
    • Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
    • +2 more
    • tabelecleucel
    • La Jolla, California
    • +26 more
    Mar 24, 2021

    Epstein-Barr Virus Infections Trial in Strasbourg (Rituximab, control group)

    Recruiting
    • Epstein-Barr Virus Infections
    • Strasbourg, France
      Les Hôpitaux Universitaires de Strasbourg
    Dec 7, 2021

    Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,

    Recruiting
    • Lymphoproliferative Disorders
    • +4 more
    • Busulfan test dose
    • +8 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)

    Not yet recruiting
    • Acute Leukemia
    • Rifaximin with allogeneic stem cell transplant
    • Allogeneic stem cell transplant
    • (no location specified)
    Sep 21, 2023

    Post-Transplant Lymphoproliferative Disorder, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Seattle

    Not yet recruiting
    • Post-Transplant Lymphoproliferative Disorder
    • +10 more
    • Loncastuximab Tesirine
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 6, 2022

    Post-Lyme Disease Syndrome Trial (Tetracycline 500 Mg, Placebo)

    Enrolling by invitation
    • Post-Treatment Lyme Disease
    • Tetracycline 500 Mg
    • Placebo
    • Lutherville, Maryland
      Johns Hopkins Lyme Disease Research Center
    Nov 4, 2022

    Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

    Active, not recruiting
    • Chronic Granulomatous Disease Transplant
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Pediatric Heart Transplantation, Immunosuppression, Chronic Kidney Diseases Trial in United States (Everolimus, Tacrolimus,

    Active, not recruiting
    • Pediatric Heart Transplantation
    • +6 more
    • Birmingham, Alabama
    • +24 more
    Sep 2, 2021

    Kidney Transplant Trial in Canada, United States (Sirolimus, Belatacept, Mycophenolate Mofetil)

    Not yet recruiting
    • Kidney Transplant
    • Birmingham, Alabama
    • +17 more
    Sep 20, 2023

    Multiple Myeloma Trial (Dexamethasone, Isatuximab, Lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Jan 10, 2023

    Focal Segmental Glomerulosclerosis and Minimal Change Disease

    Not yet recruiting
    • Focal Segmental Glomerulosclerosis
    • +3 more
    • Biospecimen collection
    • Data collection
    • Ann Arbor, Michigan
      University of Michigan
    Dec 6, 2022

    Metastatic Cancer, Solid Tumor Cancer, Lymphoproliferative Disorders Trial in Boulder (Written Exposure Therapy)

    Recruiting
    • Metastatic Cancer
    • +5 more
    • Written Exposure Therapy
    • Boulder, Colorado
      University of Colorado Boulder
    Sep 13, 2023

    MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)

    Recruiting
    • Myelodysplastic Syndromes
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 18, 2023

    Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)

    Recruiting
    • Epstein-Barr Virus Infections
    • +2 more
    • Group A
    • Group B
    • Montreal, Quebec, Canada
      Hôpital Maisonneuve-Rosemont
    Apr 5, 2022